An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

NCT03337906 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 209

Last updated 2022-04-18

No results posted yet for this study

Summary

An observational study of long-term outcomes of HIV-1 infection in persons who become infected after enrollment in HIV-1 vaccine trials

Conditions

  • HIV Infections

Interventions

OTHER

Observation

Sponsors & Collaborators

  • HIV Vaccine Trials Network

    lead NETWORK

Principal Investigators

  • Magdalena Sobieszcyk · Columbia University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-11
Primary Completion
2015-07-11
Completion
2016-07-01

Countries

  • United States
  • Dominican Republic
  • Haiti
  • Peru
  • Puerto Rico
  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03337906 on ClinicalTrials.gov